Acquisition of Bio Pharma Services Inc. (“BioPharma”) expected to double Think’s pro forma 2021 revenue to $82 million.
Toronto, ON, September 13, 2021 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has closed its previously announced acquisition of all of the issued and outstanding shares of BioPharma, a leading contract research organization to pharmaceutical companies globally, from its securityholders (the “BioPharma Securityholders”).
Think CEO Sachin Aggarwal said, “We extend a warm welcome from the Think family to the talented BioPharma team. The closing of this acquisition offers not just immediate financial value to our shareholders, but it also represents a key pillar in our knowledge lifecycle, allowing us to utilize systems and solutions that support the clinical decision-making process, standardize care, and, ultimately, improve patient outcomes. We look forward to supporting BioPharma in its digital transformation to create synergies in the near term.”
Visit the Think Research website to view the full release.